Back to Search
Start Over
Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.
- Source :
-
British journal of haematology [Br J Haematol] 2022 May; Vol. 197 (4), pp. 502-504. Date of Electronic Publication: 2022 Feb 21. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 197
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 35189668
- Full Text :
- https://doi.org/10.1111/bjh.18059